Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study.

Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Mar; 108(3):493-9.

View in: PubMed

subject areas

Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Cetuximab
Drug Administration Schedule
Drug Resistance, Neoplasm
ErbB Receptors
Female
Gene Expression Regulation, Neoplastic
Humans
Infusions, Intravenous
Middle Aged
Neoplasm Recurrence, Local
Neoplasms, Hormone-Dependent
Ovarian Neoplasms
Treatment Outcome

authors with profiles

Robert S Mannel